"I'll take my loss"That would only be if you were silly enough...

"I'll take my loss"

That would only be if you were silly enough to sell Tulips.

How long do you think it will stay "low".

The Expert Report states that ResAppDx will only require $1 million to complete full development. That's a very small CR and RAP will now have a much higher profile in financial circles than it had a couple of months ago. I have posted a number of times previously on what that actual revenue input from ResAppDx could be - using the data in the Report.

Even if Covid revenue were to never come about (the concept that some posters are trying to suggest despite the fact that Pfizer want the Covid research results) the extraordinarily conservative Report values RAP at 14.0 cents without the Covid related input [that's 20.8*(199 - 65.5)/199] from Table 7 in the acuity report for those who want to do the calculation].

The company is publicly recognised now as having substantially larger value than reflected in its share price prior to this disgraceful exercise. There will be those waiting for the opportunity for such a "fall".

poorinvestor